Skip to main content
Equibles

Julianne Averill

CFO

Armata Pharmaceuticals, Inc. (ARMP)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Julianne Averill

Julianne Averill is recorded as CFO at Armata Pharmaceuticals, Inc. (ARMP). Armata Pharmaceuticals, Inc. reported in an 8-K filed September 20, 2023 that Julianne Averill resigned as Chief Financial Officer, effective September 15, 2023. Armata Pharmaceuticals, Inc. reported in an 8-K filed May 5, 2023 that Julianne Averill was appointed Chief Financial Officer, effective May 2, 2023.

“On September 15, 2023, Richard Rychlik, Corporate Controller of Armata Pharmaceuticals, Inc. (“Armata” or the “Company”), was promoted to serve as Armata’s principal financial officer, replacing Julianne Averill of Danforth Advisors, LLC, who resigned as Chief Financial Officer on the same day.”
Armata Pharmaceuticals, Inc. Form 8-K, filed September 20, 2023 · Read the filing
“On May 4, 2023, the Company's Board of Directors (the "Board") appointed Julianne Averill to serve, effective as of May 2, 2023, as Chief Financial Officer of the Company and in such capacity, also serve as principal financial officer and principal accounting officer of the Company.”
Armata Pharmaceuticals, Inc. Form 8-K, filed May 5, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Armata Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.